Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachiko Okamoto

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Scientific Reports|October 9, 2015
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responsesJunko Matsuzaki, Takemasa Tsuji, Immanuel F Luescher, et al.
Neuro-Oncology|March 6, 2013
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma modelKenichiro Iwami, Atsushi Natsume, Masasuke Ohno, et al.
Cancer Immunology Research|April 30, 2014
Gene-modified human α/β-T cells expressing a chimeric CD16-CD3ζ receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapyFumihiro Ochi, Hiroshi Fujiwara, Kazushi Tanimoto, et al.
STAR Protocols|November 3, 2024
Protocol to measure human IL-6 secretion from CAR T cell-primed macrophage and monocyte lineage cells in vitro and in vivo using humanized miceThao Nguyen, Toshiaki Yoshikawa, Yusuke Ito, et al.
Cell Reports. Medicine|April 26, 2024
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cellsToshiaki Yoshikawa, Yusuke Ito, Zhiwen Wu, et al.
Blood|May 4, 2013
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemiaYukihiro Miyazaki, Hiroshi Fujiwara, Hiroaki Asai, et al.
Plos One|February 27, 2013
Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptorHiroaki Asai, Hiroshi Fujiwara, Jun An, et al.
Cancer Immunology Research|July 3, 2026
Enhancement of ferroptosis in escape variant tumor cells by IFN-γ derived from antigen-specific T cells controls tumor with heterogeneityDaisuke Ehara, Kiyoshi Yasui, Mitsuhiro Yoneda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2016
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell LeukemiaHiroki Tanaka, Hiroshi Fujiwara, Fumihiro Ochi, et al.
International Journal of Molecular Sciences|July 14, 2023
CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive ImmunotherapyYizheng Wang, Linan Wang, Naohiro Seo, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|October 9, 2015
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responsesJunko Matsuzaki, Takemasa Tsuji, Immanuel F Luescher, et al.
Neuro-Oncology|March 6, 2013
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma modelKenichiro Iwami, Atsushi Natsume, Masasuke Ohno, et al.
Cancer Immunology Research|April 30, 2014
Gene-modified human α/β-T cells expressing a chimeric CD16-CD3ζ receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapyFumihiro Ochi, Hiroshi Fujiwara, Kazushi Tanimoto, et al.
STAR Protocols|November 3, 2024
Protocol to measure human IL-6 secretion from CAR T cell-primed macrophage and monocyte lineage cells in vitro and in vivo using humanized miceThao Nguyen, Toshiaki Yoshikawa, Yusuke Ito, et al.
Cell Reports. Medicine|April 26, 2024
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cellsToshiaki Yoshikawa, Yusuke Ito, Zhiwen Wu, et al.
Blood|May 4, 2013
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemiaYukihiro Miyazaki, Hiroshi Fujiwara, Hiroaki Asai, et al.
Plos One|February 27, 2013
Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptorHiroaki Asai, Hiroshi Fujiwara, Jun An, et al.
Cancer Immunology Research|July 3, 2026
Enhancement of ferroptosis in escape variant tumor cells by IFN-γ derived from antigen-specific T cells controls tumor with heterogeneityDaisuke Ehara, Kiyoshi Yasui, Mitsuhiro Yoneda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2016
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell LeukemiaHiroki Tanaka, Hiroshi Fujiwara, Fumihiro Ochi, et al.
International Journal of Molecular Sciences|July 14, 2023
CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive ImmunotherapyYizheng Wang, Linan Wang, Naohiro Seo, et al.
Pageof 4